BAHD1 serves as a critical regulator of breast cancer cell proliferation and invasion.
Ze-Yu YangSu-Peng YinQingnan RenDeng-Wei LuTao TangYao LiYi-Zeng SunHong-Biao MoTing-Jie YinZi-Ying YiJun-Ping ZhuXiaohua ZengHongdan ChenPublished in: Breast cancer (Tokyo, Japan) (2022)
Breast cancer patients with lymphatic metastasis suffer from poor prognoses. There is an urgent need for controlling lymph node metastasis, but it has proven challenging so far. Here, we implemented LASSO analysis of The Cancer Genome Atlas database to identify genes related to lymph node metastasis and prognosis, and 15 genes were selected. We constructed a functional protein association network and univariate Cox regression to identify significant genes. The results showed that BAHD1 could be predictive of lymph node metastasis as well as prognosis. In vitro studies demonstrated that BAHD1 exerted appreciable effects on the proliferation, migration, and invasion capacity of breast cancer cells. Furthermore, downregulation of BAHD1 induced cell cycle arrest in G1 phase. Additionally, the mRNA levels of CCND1, CDK1 and YWHAZ were decreased upon BAHD1 silencing. These findings indicate that the expression of BAHD1 is essential in the progression of breast cancer, which may provide novel therapeutic and diagnostic clues and insights into the prevention of lymph node metastasis in breast cancer.
Keyphrases
- lymph node metastasis
- papillary thyroid
- squamous cell carcinoma
- genome wide
- cell cycle arrest
- breast cancer cells
- genome wide identification
- binding protein
- cell death
- bioinformatics analysis
- poor prognosis
- signaling pathway
- lymph node
- cell proliferation
- transcription factor
- wastewater treatment
- gene expression
- dna methylation
- childhood cancer
- diabetic rats
- high glucose
- emergency department
- oxidative stress
- drug induced
- long non coding rna
- breast cancer risk